Skip to main content

Moss Produces Human Collagen for Skincare

Unlike bacteria or yeast, moss can produce large polypeptides of human collagen along with the post-translational modifications that make it stable and bioactive.

Written byRebecca Roberts, PhD
| 3 min read
Two large, clear bioreactors are filled with green moss floating in water, with light tubes behind them.
Register for free to listen to this article
Listen with Speechify
0:00
3:00

Collagen is the main component of the extracellular matrix (ECM), giving structure to bones, tendons, ligaments, and skin.1 As people age and the skin accumulates damage from the sun, it’s the changes in collagen proteins in the dermis that show up as those pesky wrinkles.2

While collagen supplements are available, most of them don’t contain a bioactive form of the protein. Recently, plant biotechnologist Ralf Reski of the University of Freiburg teamed up with Swiss biotechnology company Mibelle Biochemistry to change that by producing a human collagen polypeptide in a unique model system: moss.3


A micrograph showing a single leafy stem of moss, stained red to show that it is producing collagen.

This Physcomitrella moss plant contains hundreds of copies of the human collagen III gene sequence in its cells, and has been stained red to show collagen production.

Mibelle Biochemistry

Limitations of Animal and Recombinant Collagens

While many collagen supplements promise improvements in visible signs of aging, not all collagens are made equal. The majority of the collagen supplements on the market are either derived from animals like cows or pigs or are recombinant collagens produced in yeast or bacterial systems, and each has major disadvantages.

“If you buy non-recombinant collagen, it's often hydrolyzed just to get rid of potential contaminations with other proteins which might harm you,” Reski explained of animal-derived collagens. By breaking down the collagen into smaller peptides, it is unlikely to have any bioactive effect on the skin or body.

For human collagen produced recombinantly in yeast or bacteria, there is another problem: These systems either produce only small peptides of the human collagen protein or cannot add the necessary hydroxyproline post-translational modifications that keep the larger sections of the protein stable and biologically active. “It makes no sense to have a protein that would degrade rather fast when it’s [used] in cosmetics,” Reski said. Despite these shortcomings, “the recombinant collagen [industry] is 1.5 billion US dollar sales per year,” he added.

Continue reading below...

Like this story? Sign up for FREE Cell Biology updates:

Latest science news storiesTopic-tailored resources and eventsCustomized newsletter content
Subscribe

Moss Produces Bioactive Collagen Polypeptides

Ralf Reski is smiling, wearing dark-rimmed glasses and a pale checked shirt on a white background.

Biotechnologist Ralf Reski of the University of Freiburg has spent his career growing valuable proteins in mosses.

Jürgen Gocke, CIBSS, ReskiLab

Reski knew exactly where to turn when scientists from Mibelle told him they wanted to produce human collagen that would be active in skincare; his career has largely focused on using mosses as factories for the scalable production of valuable proteins. Unlike yeast, bacterial systems, and other plants, mosses have no problem producing the complex post-translational modifications needed for human proteins, and they can be grown in large bioreactors with just sunlight and water.

Reski and his colleagues first codon-optimized a large, hydrophilic segment of the human collagen III gene for production in moss, ensuring that it contained the four key protein domains that are responsible for ECM formation and, therefore, its bioactivity. The addition of a signal sequence instructed the moss to secrete the product into the culture media, making isolation and purification far easier than in other systems.

After inserting hundreds of copies of the gene into the genome of the moss Physcomitrium patens, the team selected the best-performing lines and transferred them to large bioreactors to pump out as much protein as possible. “[This project] showed us that we have to optimize the process for every specific product differently, so we know what we should alter, like temperature, CO2, and light,” Reski said.

Long threads of moss protonema, showing green chloroplasts, on a clear background.

Reski and his colleagues inserted a large segment of the human collagen III gene into the moss, with a signal peptide to instruct the plants to secrete the protein into the surrounding media.

ReskiLab, University of Freiburg

Constant measuring allowed them to see when protein production had peaked: “At a certain day, we had a lot of the protein in the medium, so we could isolate it very easily and in high quantities.” The result was a polypeptide of human collagen that is water-soluble, bioactive, stable, and suitable for use in skincare. According to Reski, early data from functional studies are promising, with reductions in wrinkle depth when tested on human volunteers. “At the molecular level, they have skin cells [in a petri dish], and [Mibelle scientists] put the extract on them and see two relevant genes are stimulated by this moss-produced collagen,” he added.

  1. Babraj JA, et al. Collagen synthesis in human musculoskeletal tissues and skin. Am J Physiol-Endocrinol Metab. 2005;289(5):E864-E869.
  2. Chung JH, et al. Modulation of skin collagen metabolism in aged and photoaged human skin in vivo. J Invest Dermatol. 2001;117(5):1218-1224.
  3. Bohlender LL, et al. Secretion-based production of prolyl-hydroxylated human type III collagen in scalable Physcomitrella photobioreactors. Plant Cell Rep. 2026;45(2):45.
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

  • Rebecca Roberts,PhD

    Rebecca Roberts is a science writer and communicator. She earned her PhD in molecular biology from the University of the Sunshine Coast in Australia and completed a two-year postdoctoral fellowship at Lund University in Sweden. Her writing focuses on gene editing technology, cell and gene therapies, and the regulatory space.

    View Full Profile

Related Topics

You might also be interested in...
Loading Next Article...
You might also be interested in...
Loading Next Article...
The Scientist Digest cover September 2026
September 2026

Multiplex Microscopy Becomes Easier with Encoded Antibodies

A new system that enables researchers to uniquely tag monoclonal antibodies for use in microscopy could help simplify complex imaging studies.

View this Issue
Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Alamar Biosciences logo
Best Practices for qPCR Assay Design and Optimization

Best Practices for qPCR Assay Design and Optimization

Bio-Rad
Beyond the Basics: Strategies for Single-Cell and Spatial Transcriptomics Analysis

Beyond the Basics: Strategies for Single-Cell and Spatial Transcriptomics Analysis

bioxcell
Scientist reviewing cellular and molecular data on a computer in a laboratory.

Building Translation-Ready Biomarkers with Connected Workflows

Danaher Logo

Products

Closeup image of a multi channel pipette dispensing pink liquid into a 96-well plate.

The ASSIST PLUS pipetting robot for affordable workflow automation

Integra Logo
Single cells in suspension

Rapidly isolate primary cells and make uniform single-cell suspensions with Corning® Cell Strainers

Corning logo
Abstract image representing cell membranes linked together.

CellBrite® Steady Membrane Stain: Cell surface staining built for real-time imaging

Biotium
sino biological logo

Monod Bio Licenses AI-designed Protein Technologies to SignalChem Biotech for Custom Discovery Assays